Although gene expression profiling data provided by The Cancer Genome Atlas (TCGA) show that MAPK4 expression is correlated with the survival rates in patients with lung cancer, bladder cancer and glioma, its functions and mechanism of actions in lung cancer and colon cancer were recently identified [13]. The gene discussed is MAPK4; the disease is lung carcinoma.